Lenvima Side Effects
Generic Name: lenvatinib
Note: This document contains side effect information about lenvatinib. Some of the dosage forms listed on this page may not apply to the brand name Lenvima.
For the Consumer
Applies to lenvatinib: capsule oral, oral capsule
Along with its needed effects, lenvatinib (the active ingredient contained in Lenvima) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking lenvatinib:
More common- Bladder pain
- bloating or swelling of the face, arms, hands, lower legs, or feet
- changes in vision
- chest pain or discomfort
- confusion
- coughing up blood
- decreased frequency or amount of urine
- difficulty with breathing or swallowing
- dilated neck veins
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- extreme fatigue
- fainting
- increase in heart rate
- increased menstrual flow or vaginal bleeding
- lower back or side pain
- muscle cramps in the hands, arms, feet, legs, or face
- nervousness
- nosebleeds
- numbness and tingling around the mouth, fingertips, or feet
- paralysis
- rapid or irregular breathing
- rapid weight gain
- red or black, tarry stools
- red or dark brown urine
- redness, swelling, or pain of the skin
- severe headache
- slow or fast heartbeat
- swelling of the face, fingers, feet, or lower legs
- tingling of the hands or feet
- tremor
- ulceration of the skin
- unusual tiredness or weakness
- unusual bleeding or bruising
- vomiting
- wrinkled skin
- Abdominal or stomach pain or tenderness
- clay colored stools
- dark urine
- difficulty with speaking
- fever
- heartburn or indigestion
- inability to move the arms, legs, or facial muscles
- pain or discomfort in the arms, jaw, back, or neck
- severe abdominal or stomach pain, cramping, or burning
- vomiting of material that looks like coffee grounds
- yellow eyes or skin
Some side effects of lenvatinib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common- Belching
- change or loss of taste
- decreased appetite
- dry mouth
- hair loss or thinning of the hair
- headache
- hoarseness
- itching or skin rash
- muscle pain or stiffness
- nausea
- pain in the joints
- sore throat
- swelling or inflammation of the mouth
- trouble sleeping
- voice changes
For Healthcare Professionals
Applies to lenvatinib: oral capsule
Cardiovascular
Very common (10% or more): Hypertension (73%)
Common (1% to 10%): Hypotension, QT prolongation, arterial thromboembolic event, cardiac dysfunction (cardiac failure, decreased ventricular function, pulmonary edema)[Ref]
Renal
Very common (10% or more): Proteinuria (34%), renal impairment (14%)
Common (1% to 10%): Increased creatinine, renal failure[Ref]
Hematologic
Very common (10% or more): Hemorrhagic events (35%)
Common (1% to 10%): Decreased platelet count
Hepatic
Common (1% to 10%): Hyperbilirubinemia, increased alkaline phosphatase, increased ALT, increased AST
Very rare (less than 0.01%): Hepatic failure, acute hepatitis[Ref]
Gastrointestinal
Very common (10% or more): Diarrhea (67%), nausea (47%), stomatitis (41%), vomiting (36%), abdominal pain (31%), constipation (29%), oral pain (25%), dry mouth (17%), dyspepsia (13%)
Common (1% to 10%): GI perforation/fistula, increased serum amylase, increased lipase[Ref]
Nervous system
Very common (10% or more): Headache (38%), dysgeusia (18%), dizziness (15%)
Common (1% to 10%): Reversible posterior leukoencephalopathy syndrome[Ref]
Endocrine
Very common (10% or more): TSH suppression impairment (up to 88%)
Metabolic
Very common (10% or more): Decreased appetite (54%), weight decreased (51%)
Common (1% to 10%): Dehydration, hypoalbuminemia, hypomagnesemia, hypoglycemia, hypocalcemia, hypercalcemia, hyperkalemia, hypercholesterolemia[Ref]
Dermatologic
Very common (10% or more): Palmar-plantar erythrodysesthesia (32%), rash (21%), alopecia (12%)
Common (1% to 10%): Hyperkeratosis[Ref]
Genitourinary
Very common (10% or more): Urinary tract infections (11%)[Ref]
Immunologic
Very Common (10% or more): Dental and oral infections (10%)[Ref]
Musculoskeletal
Very common (10% or more): Arthralgia/myalgia (62%)[Ref]
Other
Very common (10% or more): Fatigue (67%), peripheral edema (21%)
Psychiatric
Very common (10% or more): Insomnia (12%)[Ref]
Respiratory
Very common (10% or more): Dysphonia (31%), cough (24%), epistaxis (12%)
Common (1% to 10%): Pulmonary embolism[Ref]
References
1. "Product Information. Lenvima (lenvatinib)." Eisai Inc, Woodcliff Lake, NJ.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.
More about Lenvima (lenvatinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: multikinase inhibitors